复发性剖宫产瘢痕妊娠:病例系列与文献综述
该研究通过回顾性分析六个超声数据库2010–2019年的252例剖宫产瘢痕妊娠(CSP),发现105例再次妊娠者中36例(34.3%)为复发性CSP;文献综述汇总944例可靠随访的原发CSP中,327次妊娠有67次(20.5%)为复发性CSP。未发现原CSP治疗方式与复发风险相关。
要点
- 复发性CSP比既往基于少量病例报告所认为的更常见。
- 原CSP治疗方式与复发风险无明确关联。
- CSP治疗后妊娠应鼓励在孕5–7周行经阴道超声确定妊娠位置。
核心结论
- 复发性CSP的发生率高于既往基于单病例报告或小系列所假设的水平。
- 未发现原CSP治疗方式与CSP复发之间存在明显因果关系或关联。
研究设计与样本
- 回顾性搜索六个妇产科超声数据库2010–2019年的所有CSP及复发性CSP病例。
- 数据库识别252例CSP,按治疗地点临床随访率71.4%–100%(平均90.9%)。
- PubMed检索「recurrent Cesarean scar pregnancy」和「recurrent Cesarean scar ectopic pregnancy」,纳入17篇文献。
主要发现
- 数据库252例CSP中,105例在既往CSP治疗后再次妊娠,其中36例(34.3%)为复发性CSP。
- 36例复发性CSP中,27例单次复发,3例多次复发(分别2、3、4次)。
- 文献综述报告1743例原发CSP诊断,其中944例有可靠随访。
- 文献中489例尝试再次妊娠,327次妊娠中67次(20.5%)为复发性CSP。
关键数值与推荐
- 数据库随访:105例再次妊娠者中36例(34.3%)为复发性CSP。
- 文献汇总:327次妊娠中67次(20.5%)为复发性CSP。
- 推荐CSP治疗后妊娠者在孕5–7周行经阴道超声确定妊娠位置。
临床怎么用
- 对CSP治疗后有再生育需求者,应告知复发性CSP风险可能高于既往认知。
- CSP治疗后妊娠应尽早(孕5–7周)行经阴道超声确认妊娠位置。
- 选择原CSP治疗方式时,无需以降低复发风险为主要考量。
局限性
- 数据库随访率因治疗地点而异(71.4%–100%),存在随访不完整可能。
- 文献综述纳入研究多为单病例报告或小系列,数据可靠性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the rate of recurrent Cesarean scar pregnancy (CSP) in our clinical practices and to evaluate whether the mode of treatment of a CSP is associated with the risk of recurrent CSP, as well as to review the published literature on recurrent CSP. METHODS: We performed a retrospective search of our six obstetric and gynecological departmental ultrasound databases for all CSPs and recurrent CSPs between 2010 and 2019. We extracted various data, including number of CSPs with follow-up, number of cases attempting and number achieving pregnancy following treatment of CSP and number of recurrent CSPs, as well as details of the treatment of the original CSP. After analyzing the clinical data, we evaluated whether the mode of treatment terminating the previous CSP was associated with the risk of recurrent CSP. We also performed a PubMed search for: 'recurrent Cesarean scar pregnancy' and 'recurrent Cesarean scar ectopic pregnancy'. Articles were reviewed for year of publication, and extraction and analysis of the same data as those obtained from our departmental databases were performed. RESULTS: Our database search identified 252 cases of CSP. The overall rate of clinical follow-up ranged between 71.4% and 100%, according to treatment site (mean, 90.9%). Among these, 105 women had another pregnancy after treatment of the previous CSP. Of these, 36 (34.3%) pregnancies were recurrent CSP, with 27 women having a single recurrence and three women having multiple recurrences, one with two, one with three and one with four. We did not find any particular single or combination treatment mode terminating the previous CSP to be associated with recurrent CSP. The literature search identified 17 articles that yielded sufficient information for us to evaluate their reported prevalence of recurrent CSP. These reported 1743 primary diagnoses of CSP, of which 944 had reliable follow-up. Data were available for 489 cases that attempted to conceive again after treatment of a previous CSP, and on the 327 pregnancies achieved. Of these, 67 (20.5%) were recurrent CSP. CONCLUSIONS: On the basis of our pooled clinical data and review of the literature, recurrent CSP is apparently more common than was previously assumed based upon mostly single-case reports or series with few cases. This should be borne in mind when counseling patients undergoing treatment for CSP regarding their risk of recurrence. We found no obvious causal relationship or association between the type of treatment of the previous CSP and recurrence of CSP. Patients who become pregnant after treatment of a CSP should be encouraged to have an early (5-7-week) first-trimester transvaginal scan to determine the location of the gestation. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Timor-Tritsch IE, Horwitz G, D'Antonio F, et al. Recurrent Cesarean scar pregnancy: case series and literature review. Ultrasound Obstet Gynecol. 2021. PMID: 33411387. doi:10.1002/uog.23577
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。